Dyka, Frank M.
University of Florida
5 papers on CoChatORCID 0000-0001-7973-7125
Most cited papers
- Verified
Dual AAV-mediated gene therapy restores hearing in a DFNB9 mouse model
Akil, O., Dyka, F., Calvet, C., Emptoz, A., Lahlou, G., Nouaille, S., Boutet de Monvel, J., Hardelin, J.-P., Hauswirth, W. W., Avan, P., et al. (2019) · Proceedings of the National Academy of Sciences
Hearing, Cochlea, Tinnitus, GeneticsVirus-based gene therapy research
Cited by 300
- Verified
Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors
Kay, C. N., Ryals, R. C., Aslanidi, G. V., Min, S. H., Ruan, Q., Sun, J., Dyka, F. M., Kasuga, D., Ayala, A. E., Van Vliet, K., et al. (2013) · PLoS ONE
Virus-based gene therapy researchRetinal Development and Disorders
Cited by 168
- Verified
Dual Adeno-Associated Virus Vectors Result in Efficient In Vitro and In Vivo Expression of an Oversized Gene, MYO7A
Dyka, F. M., Boye, S. L., Chiodo, V. A., Hauswirth, W. W., & Boye, S. E. (2014) · Human Gene Therapy Methods
Virus-based gene therapy researchRetinal Development and Disorders
Cited by 128
- Verified
Retinal gene therapy with a large MYO7A cDNA using adeno-associated virus
Lopes, V. S., Boye, S. E., Louie, C. M., Boye, S., Dyka, F., Chiodo, V, Fofo, H., Hauswirth, W. W., & Williams, D. S. (2013) · Gene Therapy
Virus-based gene therapy researchRetinal Development and Disorders
Cited by 112
- Verified
Dual ABCA4 -AAV Vector Treatment Reduces Pathogenic Retinal A2E Accumulation in a Mouse Model of Autosomal Recessive Stargardt Disease
Dyka, F. M., Molday, L. L., Chiodo, V. A., Molday, R. S., & Hauswirth, W. W. (2019) · Human Gene Therapy
Retinal Development and DisordersVirus-based gene therapy research
Cited by 56
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free